Vimarsana
Biggest News Aggregation in the World

Page 4 - Applied Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Applied Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Applied Testing Today - Breaking & Trending Today

QIAGEN N.V. to Release Results for Q4 and Full-Year Results 2022 and Hold Webcast - Vimarsana News

QIAGEN N.V. to Release Results for Q4 and Full-Year Results 2022 and Hold Webcast

QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the fourth quarter and full-year 2022. Press release date time: Tuesday, February 7, shortly after

QIAGEN Launches EZ2 Connect MDx Platform for Automated Sample Processing in Diagnostic Labs - Vimarsana News

QIAGEN Launches EZ2 Connect MDx Platform for Automated Sample Processing in Diagnostic Labs

Start of worldwide diagnostic use follows the launch of upgraded EZ2 Connect for research use in 2021, builds on the success of EZ1 Connect platform found in thousands of labs worldwide EZ2... | January 17, 2023

QIAGEN N.V. to Release Results for Q4 and Full-Year Results 2022 and Hold Webcast - Vimarsana News

QIAGEN N.V. to Release Results for Q4 and Full-Year Results 2022 and Hold Webcast

17.01.2023 - QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the fourth quarter and full-year 2022. Press release date / time: Tuesday, February 7, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 ...

Qiagen Completes Acquisition of Verogen - Vimarsana News

Qiagen Completes Acquisition of Verogen

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Helix and QIAGEN Form Exclusive Global Partnership to Develop and Commercialize Companion Diagnostics for Hereditary Diseases - Vimarsana News

Helix and QIAGEN Form Exclusive Global Partnership to Develop and Commercialize Companion Diagnostics for Hereditary Diseases

Partnership to leverage the Helix® Laboratory Platform and QIAGEN's biopharma relationships, NGS capabilities, and global regulatory expertise Addressing...